Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
shizu tsukada, Ph.D.
Associate Director
Takeda Pharmaceutical Company Limited, Japan
Poster(s):
(W1230-09-55) Formulation Development of Novel T-Cell Targeting Ligand-Conjugated Lipid Nanoparticles for In Situ CAR-T Cell Therapy Using Model mRNAs
Wednesday, November 12, 2025
12:30 PM - 1:30 PM
CT
